Jazz Pharmaceuticals plc — Director's Dealing 2015

Aug 31, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2015-08-27

Reporting Person: ENRIGHT PATRICK G (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-08-27	Ordinary Shares	S	425	$167.87	Disposed	1734	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	274500	Indirect
Ordinary Shares	5500	Indirect

Footnotes

F1: The Reporting Person is a managing member of Longitude Capital Partners, LLC, the general partner of each of Longitude Venture Partners, L.P. and Longitude Capital Associates, L.P. The Reporting Person disclaims beneficial ownership of the securities of the Issuer held by Longitude Venture Partners, L.P. and Longitude Capital Associates, L.P. except to the extent of his pecuniary interest therein.